FDA Inspection 1216053 - Gland Pharma Limited, Units I+II Pashamylaram Site - August 26, 2023

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Gland Pharma Limited, Units I+II Pashamylaram Site

Record Details

This FDA Inspection record concerns Gland Pharma Limited, Units I+II Pashamylaram Site, with an inspection on August 26, 2023, issued by the Center for Devices and Radiological Health, covering devices.

Company: Gland Pharma Limited, Units I+II Pashamylaram Site
Inspection Date: August 26, 2023
Product Type: Devices
Office: Center for Devices and Radiological Health

Open in Dashboard

ID · 955ba795-ebdd-4ebb-861f-16909163e529

Violation Codes2

21 CFR 820.18621 CFR 820.70(g)

Full citation text and observation details available on the Dashboard.